Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variants associated mRNA stability in lung.

BMC genomics·2022
Same author

Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer.

PLoS computational biology·2022
Same author

Comparison of the diagnostic efficacy of <sup>68</sup> Ga-FAPI-04 PET/MR and <sup>18</sup>F-FDG PET/CT in patients with pancreatic cancer.

European journal of nuclear medicine and molecular imaging·2022
Same author

Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.

American journal of epidemiology·2022
Same author

68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in a Case of Peutz-Jeghers Syndrome.

Clinical nuclear medicine·2022
Same author

Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.

Journal of diabetes and its complications·2022

Related Experiment Video

Updated: Jul 5, 2026

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
07:13

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

Electrochemiluminescence immunosensor based on CdSe nanocomposites.

Guifen Jie1, Jingjing Zhang, Danchen Wang

  • 1Key Laboratory of Analytical Chemistry for Life Science, Ministry of Education of China, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, People's Republic of China.

Analytical Chemistry
|April 26, 2008
PubMed
Summary

This study presents a novel electrochemiluminescence (ECL) immunosensor using CdSe nanocrystals and carbon nanotube-chitosan. The developed sensor offers sensitive and stable detection of human IgG (HIgG) for potential protein analysis.

More Related Videos

Compact Quantum Dots for Single-molecule Imaging
17:14

Compact Quantum Dots for Single-molecule Imaging

Published on: October 9, 2012

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
07:13

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

Compact Quantum Dots for Single-molecule Imaging
17:14

Compact Quantum Dots for Single-molecule Imaging

Published on: October 9, 2012

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Area of Science:

  • Electrochemistry
  • Nanomaterials Science
  • Biotechnology

Background:

  • Electrochemical luminescence (ECL) offers sensitive detection methods.
  • Developing robust and efficient ECL biosensors is crucial for diagnostics.
  • Combining nanomaterials can enhance ECL properties and sensor performance.

Purpose of the Study:

  • To develop a novel label-free ECL immunosensor for sensitive human IgG (HIgG) detection.
  • To enhance the electrochemiluminescence intensity and stability of the sensor.
  • To investigate the sensor's performance for protein detection.

Main Methods:

  • Fabrication of a CdSe nanocrystal (NCs)/carbon nanotube-chitosan (CNT-CHIT) composite film on an Au electrode.
  • Covalent conjugation of 3-aminopropyl-triethoxysilane (APS) to enhance ECL intensity.
  • Immobilization of antibodies and detection of HIgG via the decrease in ECL signal.

Main Results:

  • The APS-modified CdSe NCs/CNT-CHIT film exhibited a 20-fold increase in ECL intensity.
  • The immunosensor demonstrated a linear response to HIgG concentration from 0.02-200 ng mL(-1).
  • A low detection limit of 0.001 ng mL(-1) was achieved for HIgG.

Conclusions:

  • The developed ECL immunosensor shows high sensitivity, specificity, speed, and stability.
  • This technique holds promise for sensitive protein detection in biological samples.
  • The combination of CdSe NCs, CNT-CHIT, and APS is effective for ECL enhancement.